aluates Reports

$ 0.0

Automative

Global Invasive Fungal Infection Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-34B7374

Global Invasive Fungal Infection Market Insights Forecast to 2028

BUY CHAPTERS

Global Invasive Fungal Infection Market Research Report 2025

Code: QYRE-Auto-34B7374

Report

July 2025

Pages:98

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Cidara Therapeutics

Basilea Pharmaceutica

Pfizer Inc

GlaxoSmithKline PLC

Bayer

Abbott

Merck

Astellas Pharma

F2G

Scynexis Inc

Associates of Cape Cod

Biorad

IMMY

Beijing Jinshanchuan

Danna Biological

Zhanjiang A and C Biological

Invasive Fungal Infection Market Size

The global market for Invasive Fungal Infection was valued at US$ 11220 million in the year 2024 and is projected to reach a revised size of US$ 15110 million by 2031, growing at a CAGR of 4.4% during the forecast period.

Invasive Fungal Infection Market

Invasive fungal infection refers to the pathological changes and pathophysiological processes of fungi that invade human tissues and blood, and grow and multiply in them, leading to tissue damage, organ dysfunction, and inflammation.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Invasive Fungal Infection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Invasive Fungal Infection.

The Invasive Fungal Infection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Invasive Fungal Infection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Invasive Fungal Infection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Invasive Fungal Infection Market Report

Report Metric	Details
Report Name	Invasive Fungal Infection Market
Accounted market size in year	US$ 11220 million
Forecasted market size in 2031	US$ 15110 million
CAGR	4.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Diagnosis Treatment
Segment by Application	Yeast-like Fungi Filamentous Fungi Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Cidara Therapeutics, Basilea Pharmaceutica, Pfizer, GlaxoSmithKline, Bayer, Abbott, Merck, Astellas Pharma, F2G, Scynexis, Associates of Cape Cod, BioRad, IMMY, Beijing Jinshanchuan, Danna Biological, Zhanjiang A and C Biological
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Invasive Fungal Infection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Invasive Fungal Infection Market growing?

Ans: The Invasive Fungal Infection Market witnessing a CAGR of 4.4% during the forecast period 2025-2031.

What is the Invasive Fungal Infection Market size in 2031?

Ans: The Invasive Fungal Infection Market size in 2031 will be US$ 15110 million.

Who are the main players in the Invasive Fungal Infection Market report?

Ans: The main players in the Invasive Fungal Infection Market are Cidara Therapeutics, Basilea Pharmaceutica, Pfizer, GlaxoSmithKline, Bayer, Abbott, Merck, Astellas Pharma, F2G, Scynexis, Associates of Cape Cod, BioRad, IMMY, Beijing Jinshanchuan, Danna Biological, Zhanjiang A and C Biological

What are the Application segmentation covered in the Invasive Fungal Infection Market report?

Ans: The Applications covered in the Invasive Fungal Infection Market report are Yeast-like Fungi, Filamentous Fungi, Other

What are the Type segmentation covered in the Invasive Fungal Infection Market report?

Ans: The Types covered in the Invasive Fungal Infection Market report are Diagnosis, Treatment

Recommended Reports

Fungal Infection Drugs

Infectious Disease Diagnostics

Broader Anti-Infectives

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Invasive Fungal Infection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Diagnosis

1.2.3 Treatment

1.3 Market by Application

1.3.1 Global Invasive Fungal Infection Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Yeast-like Fungi

1.3.3 Filamentous Fungi

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Invasive Fungal Infection Market Perspective (2020-2031)

2.2 Global Invasive Fungal Infection Growth Trends by Region

2.2.1 Global Invasive Fungal Infection Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Invasive Fungal Infection Historic Market Size by Region (2020-2025)

2.2.3 Invasive Fungal Infection Forecasted Market Size by Region (2026-2031)

2.3 Invasive Fungal Infection Market Dynamics

2.3.1 Invasive Fungal Infection Industry Trends

2.3.2 Invasive Fungal Infection Market Drivers

2.3.3 Invasive Fungal Infection Market Challenges

2.3.4 Invasive Fungal Infection Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Invasive Fungal Infection Players by Revenue

3.1.1 Global Top Invasive Fungal Infection Players by Revenue (2020-2025)

3.1.2 Global Invasive Fungal Infection Revenue Market Share by Players (2020-2025)

3.2 Global Invasive Fungal Infection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Invasive Fungal Infection Revenue

3.4 Global Invasive Fungal Infection Market Concentration Ratio

3.4.1 Global Invasive Fungal Infection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Invasive Fungal Infection Revenue in 2024

3.5 Global Key Players of Invasive Fungal Infection Head office and Area Served

3.6 Global Key Players of Invasive Fungal Infection, Product and Application

3.7 Global Key Players of Invasive Fungal Infection, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Invasive Fungal Infection Breakdown Data by Type

4.1 Global Invasive Fungal Infection Historic Market Size by Type (2020-2025)

4.2 Global Invasive Fungal Infection Forecasted Market Size by Type (2026-2031)

5 Invasive Fungal Infection Breakdown Data by Application

5.1 Global Invasive Fungal Infection Historic Market Size by Application (2020-2025)

5.2 Global Invasive Fungal Infection Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Invasive Fungal Infection Market Size (2020-2031)

6.2 North America Invasive Fungal Infection Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Invasive Fungal Infection Market Size by Country (2020-2025)

6.4 North America Invasive Fungal Infection Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Invasive Fungal Infection Market Size (2020-2031)

7.2 Europe Invasive Fungal Infection Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Invasive Fungal Infection Market Size by Country (2020-2025)

7.4 Europe Invasive Fungal Infection Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Invasive Fungal Infection Market Size (2020-2031)

8.2 Asia-Pacific Invasive Fungal Infection Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Invasive Fungal Infection Market Size by Region (2020-2025)

8.4 Asia-Pacific Invasive Fungal Infection Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Invasive Fungal Infection Market Size (2020-2031)

9.2 Latin America Invasive Fungal Infection Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Invasive Fungal Infection Market Size by Country (2020-2025)

9.4 Latin America Invasive Fungal Infection Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Invasive Fungal Infection Market Size (2020-2031)

10.2 Middle East & Africa Invasive Fungal Infection Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Invasive Fungal Infection Market Size by Country (2020-2025)

10.4 Middle East & Africa Invasive Fungal Infection Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Cidara Therapeutics

11.1.1 Cidara Therapeutics Company Details

11.1.2 Cidara Therapeutics Business Overview

11.1.3 Cidara Therapeutics Invasive Fungal Infection Introduction

11.1.4 Cidara Therapeutics Revenue in Invasive Fungal Infection Business (2020-2025)

11.1.5 Cidara Therapeutics Recent Development

11.2 Basilea Pharmaceutica

11.2.1 Basilea Pharmaceutica Company Details

11.2.2 Basilea Pharmaceutica Business Overview

11.2.3 Basilea Pharmaceutica Invasive Fungal Infection Introduction

11.2.4 Basilea Pharmaceutica Revenue in Invasive Fungal Infection Business (2020-2025)

11.2.5 Basilea Pharmaceutica Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Invasive Fungal Infection Introduction

11.3.4 Pfizer Revenue in Invasive Fungal Infection Business (2020-2025)

11.3.5 Pfizer Recent Development

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Details

11.4.2 GlaxoSmithKline Business Overview

11.4.3 GlaxoSmithKline Invasive Fungal Infection Introduction

11.4.4 GlaxoSmithKline Revenue in Invasive Fungal Infection Business (2020-2025)

11.4.5 GlaxoSmithKline Recent Development

11.5 Bayer

11.5.1 Bayer Company Details

11.5.2 Bayer Business Overview

11.5.3 Bayer Invasive Fungal Infection Introduction

11.5.4 Bayer Revenue in Invasive Fungal Infection Business (2020-2025)

11.5.5 Bayer Recent Development

11.6 Abbott

11.6.1 Abbott Company Details

11.6.2 Abbott Business Overview

11.6.3 Abbott Invasive Fungal Infection Introduction

11.6.4 Abbott Revenue in Invasive Fungal Infection Business (2020-2025)

11.6.5 Abbott Recent Development

11.7 Merck

11.7.1 Merck Company Details

11.7.2 Merck Business Overview

11.7.3 Merck Invasive Fungal Infection Introduction

11.7.4 Merck Revenue in Invasive Fungal Infection Business (2020-2025)

11.7.5 Merck Recent Development

11.8 Astellas Pharma

11.8.1 Astellas Pharma Company Details

11.8.2 Astellas Pharma Business Overview

11.8.3 Astellas Pharma Invasive Fungal Infection Introduction

11.8.4 Astellas Pharma Revenue in Invasive Fungal Infection Business (2020-2025)

11.8.5 Astellas Pharma Recent Development

11.9 F2G

11.9.1 F2G Company Details

11.9.2 F2G Business Overview

11.9.3 F2G Invasive Fungal Infection Introduction

11.9.4 F2G Revenue in Invasive Fungal Infection Business (2020-2025)

11.9.5 F2G Recent Development

11.10 Scynexis

11.10.1 Scynexis Company Details

11.10.2 Scynexis Business Overview

11.10.3 Scynexis Invasive Fungal Infection Introduction

11.10.4 Scynexis Revenue in Invasive Fungal Infection Business (2020-2025)

11.10.5 Scynexis Recent Development

11.11 Associates of Cape Cod

11.11.1 Associates of Cape Cod Company Details

11.11.2 Associates of Cape Cod Business Overview

11.11.3 Associates of Cape Cod Invasive Fungal Infection Introduction

11.11.4 Associates of Cape Cod Revenue in Invasive Fungal Infection Business (2020-2025)

11.11.5 Associates of Cape Cod Recent Development

11.12 BioRad

11.12.1 BioRad Company Details

11.12.2 BioRad Business Overview

11.12.3 BioRad Invasive Fungal Infection Introduction

11.12.4 BioRad Revenue in Invasive Fungal Infection Business (2020-2025)

11.12.5 BioRad Recent Development

11.13 IMMY

11.13.1 IMMY Company Details

11.13.2 IMMY Business Overview

11.13.3 IMMY Invasive Fungal Infection Introduction

11.13.4 IMMY Revenue in Invasive Fungal Infection Business (2020-2025)

11.13.5 IMMY Recent Development

11.14 Beijing Jinshanchuan

11.14.1 Beijing Jinshanchuan Company Details

11.14.2 Beijing Jinshanchuan Business Overview

11.14.3 Beijing Jinshanchuan Invasive Fungal Infection Introduction

11.14.4 Beijing Jinshanchuan Revenue in Invasive Fungal Infection Business (2020-2025)

11.14.5 Beijing Jinshanchuan Recent Development

11.15 Danna Biological

11.15.1 Danna Biological Company Details

11.15.2 Danna Biological Business Overview

11.15.3 Danna Biological Invasive Fungal Infection Introduction

11.15.4 Danna Biological Revenue in Invasive Fungal Infection Business (2020-2025)

11.15.5 Danna Biological Recent Development

11.16 Zhanjiang A and C Biological

11.16.1 Zhanjiang A and C Biological Company Details

11.16.2 Zhanjiang A and C Biological Business Overview

11.16.3 Zhanjiang A and C Biological Invasive Fungal Infection Introduction

11.16.4 Zhanjiang A and C Biological Revenue in Invasive Fungal Infection Business (2020-2025)

11.16.5 Zhanjiang A and C Biological Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Cidara Therapeutics

Basilea Pharmaceutica

Pfizer Inc

GlaxoSmithKline PLC

Bayer

Abbott

Merck

Astellas Pharma

F2G

Scynexis Inc

Associates of Cape Cod

Biorad

IMMY

Beijing Jinshanchuan

Danna Biological

Zhanjiang A and C Biological

List of Tables

Table 1. Global Invasive Fungal Infection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Diagnosis

Table 3. Key Players of Treatment

Table 4. Global Invasive Fungal Infection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Invasive Fungal Infection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Invasive Fungal Infection Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Invasive Fungal Infection Market Share by Region (2020-2025)

Table 8. Global Invasive Fungal Infection Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Invasive Fungal Infection Market Share by Region (2026-2031)

Table 10. Invasive Fungal Infection Market Trends

Table 11. Invasive Fungal Infection Market Drivers

Table 12. Invasive Fungal Infection Market Challenges

Table 13. Invasive Fungal Infection Market Restraints

Table 14. Global Invasive Fungal Infection Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Invasive Fungal Infection Market Share by Players (2020-2025)

Table 16. Global Top Invasive Fungal Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Fungal Infection as of 2024)

Table 17. Ranking of Global Top Invasive Fungal Infection Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Invasive Fungal Infection Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Invasive Fungal Infection, Headquarters and Area Served

Table 20. Global Key Players of Invasive Fungal Infection, Product and Application

Table 21. Global Key Players of Invasive Fungal Infection, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Invasive Fungal Infection Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Invasive Fungal Infection Revenue Market Share by Type (2020-2025)

Table 25. Global Invasive Fungal Infection Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Invasive Fungal Infection Revenue Market Share by Type (2026-2031)

Table 27. Global Invasive Fungal Infection Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Invasive Fungal Infection Revenue Market Share by Application (2020-2025)

Table 29. Global Invasive Fungal Infection Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Invasive Fungal Infection Revenue Market Share by Application (2026-2031)

Table 31. North America Invasive Fungal Infection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Invasive Fungal Infection Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Invasive Fungal Infection Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Invasive Fungal Infection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Invasive Fungal Infection Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Invasive Fungal Infection Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Invasive Fungal Infection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Invasive Fungal Infection Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Invasive Fungal Infection Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Invasive Fungal Infection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Invasive Fungal Infection Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Invasive Fungal Infection Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Invasive Fungal Infection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Invasive Fungal Infection Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Invasive Fungal Infection Market Size by Country (2026-2031) & (US$ Million)

Table 46. Cidara Therapeutics Company Details

Table 47. Cidara Therapeutics Business Overview

Table 48. Cidara Therapeutics Invasive Fungal Infection Product

Table 49. Cidara Therapeutics Revenue in Invasive Fungal Infection Business (2020-2025) & (US$ Million)

Table 50. Cidara Therapeutics Recent Development

Table 51. Basilea Pharmaceutica Company Details

Table 52. Basilea Pharmaceutica Business Overview

Table 53. Basilea Pharmaceutica Invasive Fungal Infection Product

Table 54. Basilea Pharmaceutica Revenue in Invasive Fungal Infection Business (2020-2025) & (US$ Million)

Table 55. Basilea Pharmaceutica Recent Development

Table 56. Pfizer Company Details

Table 57. Pfizer Business Overview

Table 58. Pfizer Invasive Fungal Infection Product

Table 59. Pfizer Revenue in Invasive Fungal Infection Business (2020-2025) & (US$ Million)

Table 60. Pfizer Recent Development

Table 61. GlaxoSmithKline Company Details

Table 62. GlaxoSmithKline Business Overview

Table 63. GlaxoSmithKline Invasive Fungal Infection Product

Table 64. GlaxoSmithKline Revenue in Invasive Fungal Infection Business (2020-2025) & (US$ Million)

Table 65. GlaxoSmithKline Recent Development

Table 66. Bayer Company Details

Table 67. Bayer Business Overview

Table 68. Bayer Invasive Fungal Infection Product

Table 69. Bayer Revenue in Invasive Fungal Infection Business (2020-2025) & (US$ Million)

Table 70. Bayer Recent Development

Table 71. Abbott Company Details

Table 72. Abbott Business Overview

Table 73. Abbott Invasive Fungal Infection Product

Table 74. Abbott Revenue in Invasive Fungal Infection Business (2020-2025) & (US$ Million)

Table 75. Abbott Recent Development

Table 76. Merck Company Details

Table 77. Merck Business Overview

Table 78. Merck Invasive Fungal Infection Product

Table 79. Merck Revenue in Invasive Fungal Infection Business (2020-2025) & (US$ Million)

Table 80. Merck Recent Development

Table 81. Astellas Pharma Company Details

Table 82. Astellas Pharma Business Overview

Table 83. Astellas Pharma Invasive Fungal Infection Product

Table 84. Astellas Pharma Revenue in Invasive Fungal Infection Business (2020-2025) & (US$ Million)

Table 85. Astellas Pharma Recent Development

Table 86. F2G Company Details

Table 87. F2G Business Overview

Table 88. F2G Invasive Fungal Infection Product

Table 89. F2G Revenue in Invasive Fungal Infection Business (2020-2025) & (US$ Million)

Table 90. F2G Recent Development

Table 91. Scynexis Company Details

Table 92. Scynexis Business Overview

Table 93. Scynexis Invasive Fungal Infection Product

Table 94. Scynexis Revenue in Invasive Fungal Infection Business (2020-2025) & (US$ Million)

Table 95. Scynexis Recent Development

Table 96. Associates of Cape Cod Company Details

Table 97. Associates of Cape Cod Business Overview

Table 98. Associates of Cape Cod Invasive Fungal Infection Product

Table 99. Associates of Cape Cod Revenue in Invasive Fungal Infection Business (2020-2025) & (US$ Million)

Table 100. Associates of Cape Cod Recent Development

Table 101. BioRad Company Details

Table 102. BioRad Business Overview

Table 103. BioRad Invasive Fungal Infection Product

Table 104. BioRad Revenue in Invasive Fungal Infection Business (2020-2025) & (US$ Million)

Table 105. BioRad Recent Development

Table 106. IMMY Company Details

Table 107. IMMY Business Overview

Table 108. IMMY Invasive Fungal Infection Product

Table 109. IMMY Revenue in Invasive Fungal Infection Business (2020-2025) & (US$ Million)

Table 110. IMMY Recent Development

Table 111. Beijing Jinshanchuan Company Details

Table 112. Beijing Jinshanchuan Business Overview

Table 113. Beijing Jinshanchuan Invasive Fungal Infection Product

Table 114. Beijing Jinshanchuan Revenue in Invasive Fungal Infection Business (2020-2025) & (US$ Million)

Table 115. Beijing Jinshanchuan Recent Development

Table 116. Danna Biological Company Details

Table 117. Danna Biological Business Overview

Table 118. Danna Biological Invasive Fungal Infection Product

Table 119. Danna Biological Revenue in Invasive Fungal Infection Business (2020-2025) & (US$ Million)

Table 120. Danna Biological Recent Development

Table 121. Zhanjiang A and C Biological Company Details

Table 122. Zhanjiang A and C Biological Business Overview

Table 123. Zhanjiang A and C Biological Invasive Fungal Infection Product

Table 124. Zhanjiang A and C Biological Revenue in Invasive Fungal Infection Business (2020-2025) & (US$ Million)

Table 125. Zhanjiang A and C Biological Recent Development

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

Table 129. Authors List of This Report

List of Figures

Figure 1. Invasive Fungal Infection Picture

Figure 2. Global Invasive Fungal Infection Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Invasive Fungal Infection Market Share by Type: 2024 VS 2031

Figure 4. Diagnosis Features

Figure 5. Treatment Features

Figure 6. Global Invasive Fungal Infection Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Invasive Fungal Infection Market Share by Application: 2024 VS 2031

Figure 8. Yeast-like Fungi Case Studies

Figure 9. Filamentous Fungi Case Studies

Figure 10. Other Case Studies

Figure 11. Invasive Fungal Infection Report Years Considered

Figure 12. Global Invasive Fungal Infection Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Invasive Fungal Infection Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Invasive Fungal Infection Market Share by Region: 2024 VS 2031

Figure 15. Global Invasive Fungal Infection Market Share by Players in 2024

Figure 16. Global Top Invasive Fungal Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Fungal Infection as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Invasive Fungal Infection Revenue in 2024

Figure 18. North America Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Invasive Fungal Infection Market Share by Country (2020-2031)

Figure 20. United States Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Invasive Fungal Infection Market Share by Country (2020-2031)

Figure 24. Germany Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Invasive Fungal Infection Market Share by Region (2020-2031)

Figure 32. China Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Invasive Fungal Infection Market Share by Country (2020-2031)

Figure 40. Mexico Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Invasive Fungal Infection Market Share by Country (2020-2031)

Figure 44. Turkey Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Invasive Fungal Infection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Cidara Therapeutics Revenue Growth Rate in Invasive Fungal Infection Business (2020-2025)

Figure 48. Basilea Pharmaceutica Revenue Growth Rate in Invasive Fungal Infection Business (2020-2025)

Figure 49. Pfizer Revenue Growth Rate in Invasive Fungal Infection Business (2020-2025)

Figure 50. GlaxoSmithKline Revenue Growth Rate in Invasive Fungal Infection Business (2020-2025)

Figure 51. Bayer Revenue Growth Rate in Invasive Fungal Infection Business (2020-2025)

Figure 52. Abbott Revenue Growth Rate in Invasive Fungal Infection Business (2020-2025)

Figure 53. Merck Revenue Growth Rate in Invasive Fungal Infection Business (2020-2025)

Figure 54. Astellas Pharma Revenue Growth Rate in Invasive Fungal Infection Business (2020-2025)

Figure 55. F2G Revenue Growth Rate in Invasive Fungal Infection Business (2020-2025)

Figure 56. Scynexis Revenue Growth Rate in Invasive Fungal Infection Business (2020-2025)

Figure 57. Associates of Cape Cod Revenue Growth Rate in Invasive Fungal Infection Business (2020-2025)

Figure 58. BioRad Revenue Growth Rate in Invasive Fungal Infection Business (2020-2025)

Figure 59. IMMY Revenue Growth Rate in Invasive Fungal Infection Business (2020-2025)

Figure 60. Beijing Jinshanchuan Revenue Growth Rate in Invasive Fungal Infection Business (2020-2025)

Figure 61. Danna Biological Revenue Growth Rate in Invasive Fungal Infection Business (2020-2025)

Figure 62. Zhanjiang A and C Biological Revenue Growth Rate in Invasive Fungal Infection Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Fungal Infection Rapid Diagnosis Kit Market Research Report 2024

Global Invasive Fungal Disease IFD Drugs Market Research Report 2024

Global Fungal 1 3 β D Glucan Detection Kit Market Research Report 2024

Global Fungal Infection Diagnostic Kit Market Research Report 2024

Candida Infections Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Candida Utilis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acute Invasive Aspergillosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Systemic Antifungals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Invasive Candidiasis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Sepsis Partnering Market

Global Invasive Fungal Disease IFD Infection Diagnostic Reagent Market Research Report 2025

Systemic Candidiasis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Healthcare Acquired Infection Market Insights Forecast to 2030

Global Immunological Testing for Invasive Fungal Infections Market Research Report 2024

Global Fungal Infection Antigen Test Market Research Report 2024

Invasive Fungal Infection Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diagnosing Fungal Infections Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Candida Infection Testing Market Research Report 2025

Infectious Immunology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions